T1	intervention 30 52	weight gain prevention
T2	No-of-participants 560 572	Thirty-eight
T3	eligibility 573 627	newly diagnosed stage II or III breast cancer patients
T4	control 675 685	usual care
T5	outcome-Measure 1033 1168	Intervention feasibility, acceptability, and preliminary effects on anthropometric, quality of life, and circulating biomarker measures
T6	outcome 1185 1219	Intervention participant retention
T7	outcome 1231 1259	in-person session attendance
T8	outcome 1415 1430	being satisfied
T9	outcome 1531 1564	reductions in waist circumference
T10	outcome 1587 1632	improvements in self-reported vitality scores
